Paragon Private Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$992K Buy
11,454
+1,035
+10% +$99.2K 0.31% 91
2025
Q4
$1M Buy
10,419
+557
+6% +$54.1K 0.31% 90
2025
Q3
$939K Buy
9,862
+726
+8% +$66.7K 0.31% 97
2025
Q2
$796K Sell
9,136
-353
-4% -$29.9K 0.32% 93
2025
Q1
$853K Sell
9,489
-478
-5% -$42.8K 0.4% 72
2024
Q4
$796K Buy
9,967
+544
+6% +$47.1K 0.37% 76
2024
Q3
$848K Buy
9,423
+836
+10% +$70.3K 0.42% 69
2024
Q2
$676K Sell
8,587
-245
-3% -$20.1K 0.38% 75
2024
Q1
$770K Buy
8,832
+244
+3% +$20.8K 0.46% 69
2023
Q4
$707K Buy
8,588
+889
+12% +$67.8K 0.49% 67
2023
Q3
$603K Buy
7,699
+595
+8% +$49.8K 0.5% 65
2023
Q2
$626K Buy
7,104
+420
+6% +$36.2K 0.5% 67
2023
Q1
$539K Buy
6,684
+1,540
+30% +$126K 0.45% 72
2022
Q4
$400K Buy
5,144
+1,247
+32% +$101K 0.36% 79
2022
Q3
$329K Buy
+3,897
New +$350K 0.32% 87

Other funds holding MDT

Paragon Private Wealth Management's MDT Position: Q1 2026 in Review

Paragon Private Wealth Management increased its Medtronic (MDT) stake by 9.9% in Q1 2026, buying an estimated $99.2K and bringing the position to 11,454 shares worth $992K. The position accounts for 0.31% of the portfolio, ranked #91.

Paragon Private Wealth Management first reported a position in MDT in Q3 2022 and has held it in 15 quarters since. The position peaked at $1M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Paragon Private Wealth Management held 11,454 shares of Medtronic worth $992K as of Q1 2026.
  • Paragon Private Wealth Management bought 1,035 Medtronic shares in Q1 2026, an estimated $99.2K.
  • Medtronic made up 0.31% of Paragon Private Wealth Management's portfolio in Q1 2026, its #91 holding.
  • Paragon Private Wealth Management first reported a position in Medtronic in Q3 2022 and has held it in 15 quarters since.
  • Paragon Private Wealth Management's Medtronic position peaked at $1M in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Paragon Private Wealth Management's 13F filing for Q1 2026, filed 19 May 2026.